BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV 0.06% -1.91% 14.30% 2.28% 73.28% 14.74% -1.02% -- 16.23% 04/07/2010
BIB Market Price 0.13% -1.80% 14.32% 2.32% 73.45% 14.71% -1.06% -- 16.23% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $77,464,965
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 5/11/2026
  • NAV
    $83.30
  • NAV Change
    $+0.12 up caret
  • Market Price
    $83.19
  • Market Price Change
    $+0.29 up caret
  • Trading Volume (M)
    17,648
  • 30-Day Median Bid Ask Spread
    0.24%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $77,464,965
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 5/11/2026
  • NAV
    $83.30
  • NAV Change
    $+0.12 up caret
  • Market Price
    $83.19
  • Market Price Change
    $+0.29 up caret
  • Trading Volume (M)
    17,648
  • 30-Day Median Bid Ask Spread
    0.24%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2026

Holdings

as of 5/11/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
4.79% GILD GILEAD SCIENCES INC -- $3,632,144.56 27,203 2369174
4.68% VRTX VERTEX PHARMACEUTICALS INC -- $3,547,941.01 8,153 2931034
4.54% AMGN AMGEN INC -- $3,440,590.01 10,439 2023607
3.85% REGN REGENERON PHARMACEUTICALS -- $2,914,516.53 4,089 2730190
1.96% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,486,864.80 5,220 B00FWN1
1.51% BIIB BIOGEN INC -- $1,143,161.25 5,775 2455965
1.48% RVMD REVOLUTION MEDICINES INC -- $1,124,514.15 7,801 BL71K91
1.30% UTHR UNITED THERAPEUTICS CORP -- $983,043.00 1,725 2430412
1.20% ARGX ARGENX SE - ADR -- $908,433.76 1,117 BDVLM39
1.16% INSM INSMED INC -- $881,714.43 8,487 2614487
1.15% RPRX ROYALTY PHARMA PLC- CL A -- $871,128.90 16,866 BMVP7Y0
1.13% ILMN ILLUMINA INC -- $857,910.20 6,020 2613990
1.08% MRNA MODERNA INC -- $822,125.36 15,547 BGSXTS3
1.08% ROIV ROIVANT SCIENCES LTD -- $816,150.72 28,182 BMW4NZ9
1.04% INCY INCYTE CORP -- $786,308.16 7,838 2471950
1.01% VTRS VIATRIS INC -- $767,034.36 45,333 BMWS3X9
0.79% NBIX NEUROCRINE BIOSCIENCES INC -- $595,131.68 3,952 2623911
0.76% ASND ASCENDIS PHARMA A/S -- $578,297.41 2,423 BWXJHM8
0.75% SMMT SUMMIT THERAPEUTICS INC -- $569,652.48 30,528 BMTVQS7
0.71% JAZZ JAZZ PHARMACEUTICALS PLC -- $541,807.03 2,423 B4Q5ZN4
0.67% EXEL EXELIXIS INC -- $508,284.75 10,225 2576941
0.66% GH GUARDANT HEALTH INC -- $499,313.73 5,163 BFXC911
0.65% BBIO BRIDGEBIO PHARMA INC -- $493,702.44 7,633 BK1KWG8
0.65% IONS IONIS PHARMACEUTICALS INC -- $490,346.90 6,505 BDJ0LS6
0.61% MEDP MEDPACE HOLDINGS INC -- $466,112.93 1,117 BDCBC61
0.59% MDGL MADRIGAL PHARMACEUTICALS INC -- $449,315.12 904 BD59BS7
0.58% AXSM AXSOME THERAPEUTICS INC -- $435,970.58 2,014 BYZR4X4
0.57% ARWR ARROWHEAD PHARMACEUTICALS IN -- $428,813.84 5,516 BYQBFJ8
0.55% BNTX BIONTECH SE-ADR -- $418,629.90 4,485 BK6H543
0.54% SNY SANOFI-ADR -- $409,445.00 9,634 2964557
0.53% BMRN BIOMARIN PHARMACEUTICAL INC -- $398,135.76 7,572 2437071
0.52% ONC BEONE MEDICINES LTD-ADR -- $391,234.25 1,259 BYYWPW6
0.48% PRAX PRAXIS PRECISION MEDICINES I -- $363,663.76 1,096 BQ721R4
0.48% CYTK CYTOKINETICS INC -- $361,616.00 4,850 BBBSBJ5
0.48% KRYS KRYSTAL BIOTECH INC -- $361,063.52 1,154 BD6JX35
0.44% TEM TEMPUS AI INC-CL A -- $331,369.48 6,838 BSLSJJ0
0.43% IBRX IMMUNITYBIO INC -- $328,300.91 40,481 BNSP0B8
0.41% HALO HALOZYME THERAPEUTICS INC -- $308,673.68 4,648 2975098
0.40% PCVX VAXCYTE INC -- $305,853.35 5,665 BKPVGH6
0.40% NUVL NUVALENT INC-A -- $301,313.10 2,882 BMVBZD3
0.39% ABVX ABIVAX SA-ADR -- $295,188.21 2,417 BLC89B2
0.36% KYMR KYMERA THERAPEUTICS INC -- $270,213.30 3,213 BMPRZV5
0.34% PTGX PROTAGONIST THERAPEUTICS INC -- $260,199.00 2,514 BDCBCD8
0.33% MIRM MIRUM PHARMACEUTICALS INC -- $252,259.92 2,376 BJDX8Y8
0.33% PTCT PTC THERAPEUTICS INC -- $250,377.30 3,258 B17VCN9
0.31% SYRE SPYRE THERAPEUTICS INC -- $236,321.56 3,092 BQBBDY8
0.31% RYTM RHYTHM PHARMACEUTICALS INC -- $235,079.10 2,690 BF2YWG4
0.31% IMVT IMMUNOVANT INC -- $232,974.02 8,017 BJRFSB7
0.31% ALKS ALKERMES PLC -- $232,754.14 6,562 B3P6D26
0.30% CGON CG ONCOLOGY INC -- $230,489.00 3,325 BRBCSP4
0.29% COGT COGENT BIOSCIENCES INC -- $217,967.20 6,392 BLR6XK8
0.27% APLS APELLIS PHARMACEUTICALS INC -- $206,453.66 5,033 BYTQ6X1
0.27% CRSP CRISPR THERAPEUTICS AG -- $204,103.79 3,779 BDHF4K6
0.26% SRRK SCHOLAR ROCK HOLDING CORP -- $194,270.30 4,018 BFZQ0L8
0.25% INDV INDIVIOR PHARMACEUTICALS INC -- $191,170.48 4,922 BTZRLN8
0.25% CNTA CENTESSA PHARMACEUTICALS-ADR -- $186,429.31 4,709 BLB0YQ9
0.24% XENE XENON PHARMACEUTICALS INC -- $182,735.28 3,276 BRJ3GY4
0.24% APGE APOGEE THERAPEUTICS INC -- $182,651.40 2,159 BM9HHL5
0.24% -- NEWAMSTERDAM PHARMA CO NV -- $179,184.34 4,526 BP8JSP4
0.23% CAI CARIS LIFE SCIENCES INC -- $177,093.40 11,110 BT18HP9
0.23% LGND LIGAND PHARMACEUTICALS -- $172,856.32 784 2501578
0.21% AMRX AMNEAL PHARMACEUTICALS INC -- $158,318.64 12,388 BFNF1D6
0.21% TVTX TRAVERE THERAPEUTICS INC -- $158,071.83 3,633 BLFGJD5
0.20% CRNX CRINETICS PHARMACEUTICALS IN -- $150,659.10 4,122 BDD19F8
0.19% ACAD ACADIA PHARMACEUTICALS INC -- $146,299.80 6,711 2713317
0.19% EWTX EDGEWISE THERAPEUTICS INC -- $145,981.44 4,224 BKY5JZ8
0.18% TWST TWIST BIOSCIENCE CORP -- $135,690.94 2,414 BGKG6G7
0.17% BEAM BEAM THERAPEUTICS INC -- $127,349.25 4,011 BK6L288
0.17% ERAS ERASCA INC -- $127,274.04 12,191 BNLYBF3
0.17% ORKA ORUKA THERAPEUTICS INC -- $125,186.08 1,906 BKVF0J2
0.16% TNGX TANGO THERAPEUTICS INC -- $124,490.96 5,302 BP2P6L0
0.16% VCYT VERACYTE INC -- $124,300.70 3,131 BFTWZY0
0.16% DNLI DENALI THERAPEUTICS INC -- $122,819.48 6,244 BD2B4V0
0.16% DYN DYNE THERAPEUTICS INC -- $119,657.72 6,482 BN15WD1
0.16% ALMS ALUMIS INC -- $117,779.48 4,978 BPLQG36
0.16% GPCR STRUCTURE THERAPEUTICS INC -- $117,604.08 3,069 BQS9486
0.15% SUPN SUPERNUS PHARMACEUTICALS INC -- $111,477.46 2,258 B72ZBG4
0.14% KNSA KINIKSA PHARMACEUTICALS INTE -- $105,532.96 1,808 BRXB0C0
0.14% IRON DISC MEDICINE INC -- $104,121.92 1,504 BMGJZJ8
0.14% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $103,651.20 4,880 BKX9VD3
0.14% VERA VERA THERAPEUTICS INC -- $102,874.10 2,810 BL55460
0.13% RARE ULTRAGENYX PHARMACEUTICAL IN -- $100,071.50 3,805 BJ62Z18
0.13% TARS TARSUS PHARMACEUTICALS INC -- $99,973.40 1,676 BMH5RL1
0.13% IDYA IDEAYA BIOSCIENCES INC -- $97,301.67 3,459 BK0VHF6
0.13% KOD KODIAK SCIENCES INC -- $95,719.70 2,402 BFXC933
0.13% TXG 10X GENOMICS INC-CLASS A -- $94,956.00 4,632 BKS3RS7
0.12% GRAL GRAIL INC -- $93,850.32 1,532 BSLSSX7
0.12% MLYS MINERALYS THERAPEUTICS INC -- $92,638.68 3,116 BP9N0G0
0.12% ELVN ENLIVEN THERAPEUTICS INC -- $92,601.01 2,339 BMFD115
0.12% RLAY RELAY THERAPEUTICS INC -- $90,425.45 7,037 BN2R582
0.11% LEGN LEGEND BIOTECH CORP-ADR -- $85,002.34 3,323 BMX9K07
0.11% BCRX BIOCRYST PHARMACEUTICALS INC -- $84,736.08 9,876 2100362
0.11% DFTX DEFINIUM THERAPEUTICS INC -- $84,016.40 3,926 BV2DHY6
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $82,309.92 5,236 BFWLC09
0.11% ADPT ADAPTIVE BIOTECHNOLOGIES -- $82,093.02 6,063 BJ5FZ74
0.11% NVCR NOVOCURE LTD -- $81,088.00 4,480 BYSS4X4
0.11% SION SIONNA THERAPEUTICS INC -- $80,780.10 1,758 BQKXDX4
0.11% SRPT SAREPTA THERAPEUTICS INC -- $80,044.40 4,126 B8DPDT7
0.10% OCUL OCULAR THERAPEUTIX INC -- $79,538.88 8,571 BNZB1X8
0.10% PHVS PHARVARIS NV -- $75,533.90 2,522 BMZ2X38
0.10% TRVI TREVI THERAPEUTICS INC -- $75,114.24 5,048 BJH9ZN0
0.10% SNDX SYNDAX PHARMACEUTICALS INC -- $74,252.74 3,473 BN7Q7R7
0.10% ANAB ANAPTYSBIO INC -- $74,236.56 1,093 BDRW1L7
0.10% ADMA ADMA BIOLOGICS INC -- $73,906.52 9,379 B9NSBM2
0.10% TSHA TAYSHA GENE THERAPIES INC -- $73,546.88 10,784 BNC1BX1
0.10% STOK STOKE THERAPEUTICS INC -- $73,374.72 2,248 BJQ05Z6
0.10% INBX INHIBRX BIOSCIENCES INC -- $72,848.18 571 BNSP8K3
0.10% RAPP RAPPORT THERAPEUTICS INC -- $72,133.11 1,877 BR3T9B6
0.09% TYRA TYRA BIOSCIENCES INC -- $71,489.02 2,102 BMVNDH9
0.09% ZYME ZYMEWORKS INC -- $70,840.44 2,948 BPCQZY9
0.09% MBX MBX BIOSCIENCES INC -- $70,781.28 1,766 BQXJKH2
0.09% ANIP ANI PHARMACEUTICALS INC -- $69,500.93 883 BCDWBX6
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $68,780.22 2,279 BKSGZN7
0.09% QURE UNIQURE NV -- $67,828.56 2,454 BJFSR88
0.09% NTLA INTELLIA THERAPEUTICS INC -- $67,053.00 4,650 BYZM6C2
0.09% RXRX RECURSION PHARMACEUTICALS-A -- $66,999.52 20,552 BM9FJ13
0.09% GMAB GENMAB A/S -SP ADR -- $66,366.30 2,535 BBC9WC7
0.09% NRIX NURIX THERAPEUTICS INC -- $65,934.00 4,050 BMVLGP2
0.09% VCEL VERICEL CORP -- $65,807.08 1,999 BSBMN89
0.09% INVA INNOVIVA INC -- $65,668.32 2,916 BDDXF67
0.09% AGIO AGIOS PHARMACEUTICALS INC -- $64,544.94 2,306 BCBVTX1
0.08% AMLX AMYLYX PHARMACEUTICALS INC -- $64,370.88 4,326 BPCK358
0.08% ARDX ARDELYX INC -- $63,819.55 9,655 BN89V40
0.08% ABCL ABCELLERA BIOLOGICS INC -- $62,664.00 11,936 BL53SR3
0.08% NVAX NOVAVAX INC -- $60,923.50 6,413 BJDQXG4
0.08% GLUE MONTE ROSA THERAPEUTICS INC -- $60,840.78 3,003 BP7KZP7
0.08% IOVA IOVANCE BIOTHERAPEUTICS INC -- $60,014.00 16,220 BF0DMK7
0.08% PGEN PRECIGEN INC -- $58,522.80 13,934 BKM5C84
0.08% ATAI ATAIBECKLEY INC -- $57,767.96 14,299 BWJDYK1
0.08% URGN UROGEN PHARMA LTD -- $57,709.86 1,842 BZ7PJQ1
0.08% VIR VIR BIOTECHNOLOGY INC -- $57,467.94 6,186 BK4PZ38
0.08% BCAX BICARA THERAPEUTICS INC -- $57,185.40 2,495 BQB42F1
0.07% HROW HARROW INC -- $55,576.44 1,461 BHNDW86
0.07% FTRE FORTREA HOLDINGS INC -- $55,178.19 3,681 BRXYZ57
0.07% KALV KALVISTA PHARMACEUTICALS INC -- $53,152.90 1,990 BD06CS0
0.07% WVE WAVE LIFE SCIENCES LTD -- $52,409.91 7,413 BYZG9R0
0.07% GHRS GH RESEARCH PLC -- $51,959.44 2,444 BP6C0S2
0.07% CRVS CORVUS PHARMACEUTICALS INC -- $51,414.12 3,252 BYP80F1
0.07% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $49,795.10 1,726 BLCD809
0.06% MAZE MAZE THERAPEUTICS INC -- $48,334.88 1,894 BSRK699
0.06% AVBP ARRIVENT BIOPHARMA INC -- $47,244.56 1,628 BMGTLY5
0.06% OLMA OLEMA PHARMACEUTICALS INC -- $46,883.30 3,155 BMZ4LN0
0.06% ALVO ALVOTECH SA -- $46,687.95 13,005 BPNTJ34
0.06% EYPT EYEPOINT INC -- $45,560.82 3,259 BMGS7L1
0.06% COLL COLLEGIUM PHARMACEUTICAL INC -- $44,762.50 1,250 BX7RSN3
0.06% ZBIO ZENAS BIOPHARMA INC -- $43,798.80 2,147 BQB42H3
0.05% SEPN SEPTERNA INC -- $41,506.77 1,761 BQNKXX2
0.05% SVRA SAVARA INC -- $41,036.80 8,015 BYXGN81
0.05% MNKD MANNKIND CORP -- $40,763.52 12,132 BF081J4
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $40,118.76 6,534 BLR7H87
0.05% OMER OMEROS CORP -- $40,064.40 2,790 B4NB858
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $37,906.44 3,102 BJLKVS6
0.05% GRFS GRIFOLS SA-ADR -- $37,447.80 4,801 B8K7T65
0.05% SANA SANA BIOTECHNOLOGY INC -- $37,340.84 10,489 BMFJJ97
0.05% XNCR XENCOR INC -- $36,950.31 2,889 BGCYWN8
0.05% PCRX PACIRA BIOSCIENCES INC -- $36,179.34 1,591 B3X26D8
0.05% CMPS COMPASS PATHWAYS PLC -- $35,840.10 3,714 BMC3HS7
0.05% ORIC ORIC PHARMACEUTICALS INC -- $35,528.48 3,952 BKVDFF7
0.05% DSGN DESIGN THERAPEUTICS INC -- $34,982.01 2,241 BMFK3H6
0.05% GERN GERON CORP -- $34,937.65 25,135 2370381
0.05% CGEM CULLINAN THERAPEUTICS INC -- $34,291.44 2,328 BM90J52
0.05% ABSI ABSCI CORP -- $34,223.38 5,921 BN94K69
0.05% JANX JANUX THERAPEUTICS INC -- $34,109.31 2,397 BMFX8Y7
0.04% SPRY ARS PHARMACEUTICALS INC -- $33,479.80 3,893 BMCR7V2
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $33,241.08 7,572 BZ0QMB7
0.04% TBPH THERAVANCE BIOPHARMA INC -- $32,973.92 1,996 BMNDK09
0.04% AMPH AMPHASTAR PHARMACEUTICALS IN -- $32,951.70 1,786 BNFWZS4
0.04% KURA KURA ONCOLOGY INC -- $32,581.26 3,426 BYZD465
0.04% ANNX ANNEXON INC -- $32,370.32 5,699 BMVV9R5
0.04% ETON ETON PHARMACEUTICALS INC -- $31,481.20 1,055 BGL0JK3
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $31,363.20 3,168 BFYQFJ2
0.04% BIOA BIOAGE LABS INC -- $31,035.44 1,709 BT9K6D8
0.04% MESO MESOBLAST LTD- SPON ADR -- $29,876.09 2,059 BQS7491
0.04% ESPR ESPERION THERAPEUTICS INC -- $29,456.43 9,411 BBNBTD2
0.04% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $29,455.52 811 BL95N25
0.04% VOR VOR BIOPHARMA INC -- $28,238.25 1,637 BRJJYT3
0.04% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $27,321.36 5,764 BMCWKZ2
0.04% IRWD IRONWOOD PHARMACEUTICALS INC -- $26,717.19 6,407 B3MZ6K5
0.03% ZLAB ZAI LAB LTD-ADR -- $26,426.91 1,349 BD9GVY0
0.03% CTMX CYTOMX THERAPEUTICS INC -- $25,746.20 6,670 BYWVTY5
0.03% CADL CANDEL THERAPEUTICS INC -- $25,470.30 2,878 BP0TQC5
0.03% ARVN ARVINAS INC -- $24,323.88 2,518 BDZ30Q0
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $23,932.80 2,216 BLFBZ32
0.03% PSNL PERSONALIS INC -- $23,807.82 4,119 BJQ0608
0.03% CRMD CORMEDIX INC -- $23,761.32 3,102 BJ0LT31
0.03% SLDB SOLID BIOSCIENCES INC -- $23,577.60 3,070 BQHN6C7
0.03% ACRS ACLARIS THERAPEUTICS INC -- $23,497.65 4,747 BYV2W40
0.03% KYTX KYVERNA THERAPEUTICS INC -- $23,254.66 2,249 BSMLR16
0.03% PRME PRIME MEDICINE INC -- $23,026.68 7,107 BPBJFM7
0.03% CSTL CASTLE BIOSCIENCES INC -- $22,276.80 1,170 BKLCWZ3
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $21,655.53 2,007 BKLXFX5
0.03% AQST AQUESTIVE THERAPEUTICS INC -- $20,840.68 4,802 BYVQJ96
0.03% TRAX FIRST TRACKS BIOTHERAPEUTICS -- $20,504.68 1,093 BS2CR64
0.03% AURA AURA BIOSCIENCES INC -- $20,475.00 2,500 BP81R42
0.03% PRTA PROTHENA CORP PLC -- $20,471.39 2,117 B91XRN2
0.03% TECX TECTONIC THERAPEUTIC INC -- $20,392.32 741 BPBPCG8
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $20,178.00 8,850 BFZNYB7
0.03% RGNX REGENXBIO INC -- $20,089.44 1,993 BZ0G875
0.03% UPB UPSTREAM BIO INC -- $19,376.97 2,127 BRCFFK6
0.03% KMDA KAMADA LTD -- $19,198.40 2,272 B2Q9833
0.02% NGNE NEUROGENE INC -- $18,812.01 609 BS2F741
0.02% RIGL RIGEL PHARMACEUTICALS INC -- $18,785.40 717 BQD3J33
0.02% FULC FULCRUM THERAPEUTICS INC -- $18,354.00 2,622 BJDX8Z9
0.02% ENTA ENANTA PHARMACEUTICALS INC -- $17,686.24 1,144 B9L5200
0.02% LXEO LEXEO THERAPEUTICS INC -- $17,582.76 2,873 BQ6C357
0.02% LRMR LARIMAR THERAPEUTICS INC -- $17,484.75 4,275 BMXNGZ6
0.02% AVIR ATEA PHARMACEUTICALS INC -- $16,630.34 3,074 BLN9Z50
0.02% IVVD INVIVYD INC -- $16,474.10 10,910 BM8NHS1
0.02% CTNM CONTINEUM THERAPEUTICS INC-A -- $16,366.35 1,199 BPRBTY7
0.02% EOLS EVOLUS INC -- $16,128.64 2,552 BDRJH21
0.02% PACB PACIFIC BIOSCIENCES OF CALIF -- $16,110.95 11,890 B4N8MH9
0.02% LYEL LYELL IMMUNOPHARMA INC -- $16,070.40 837 BTNMG41
0.02% LKFT LAKEFRONT BIOTHERAPEUTIC-ADR -- $16,030.80 584 B292NQ7
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $15,350.84 4,276 BDFKQ07
0.02% ALT ALTIMMUNE INC -- $15,233.70 4,930 BFY7DC4
0.02% VNDA VANDA PHARMACEUTICALS INC -- $14,665.53 2,339 B12W3P6
0.02% CABA CABALETTA BIO INC -- $14,470.16 3,788 BK5MWR1
0.02% KROS KEROS THERAPEUTICS INC -- $14,412.00 1,200 BM7V485
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $14,287.14 2,001 B7F2TY6
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $13,257.33 1,849 BL5B6Z1
0.02% IMRX IMMUNEERING CORP - CLASS A -- $13,119.60 2,523 BMVBZF5
0.02% SIGA SIGA TECHNOLOGIES INC -- $12,831.00 2,820 2107437
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $12,482.00 7,900 BFMLGR4
0.02% NMRA NEUMORA THERAPEUTICS INC -- $12,306.47 6,581 BN4JN37
0.02% LENZ LENZ THERAPEUTICS INC -- $12,297.69 1,231 BQV0J03
0.02% CCCC C4 THERAPEUTICS INC -- $12,179.14 3,842 BKX9NQ0
0.02% REPL REPLIMUNE GROUP INC -- $12,162.48 3,252 BDDVW37
0.02% AVXL ANAVEX LIFE SCIENCES CORP -- $11,826.00 3,650 BYTYP72
0.02% EDIT EDITAS MEDICINE INC -- $11,762.64 3,844 BZ8FPH3
0.02% CHRS COHERUS ONCOLOGY INC -- $11,477.70 5,886 BRK0149
0.01% ACIU AC IMMUNE SA -- $11,215.29 3,963 BZC0D70
0.01% TRDA ENTRADA THERAPEUTICS INC -- $10,570.00 1,510 BP81RK8
0.01% FHTX FOGHORN THERAPEUTICS INC -- $9,980.65 2,305 BMF7DT9
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $9,662.57 1,119 BKC9SX3
0.01% VYGR VOYAGER THERAPEUTICS INC -- $9,566.64 2,322 BY7RB53
0.01% OABI OMNIAB INC -- $9,462.22 5,666 BN13S71
0.01% CDXS CODEXIS INC -- $9,423.40 3,556 B5LL2C2
0.01% SGMT SAGIMET BIOSCIENCES INC-A -- $9,389.49 1,221 BP2NYN2
0.01% NBP NOVABRIDGE BIOSCIENCES -- $9,279.90 4,419 BKRRKY7
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $8,688.02 2,222 BPRB2N7
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $8,563.40 1,822 BKDQKM6
0.01% TNYA TENAYA THERAPEUTICS INC -- $8,518.78 8,535 BNNXX52
0.01% TKNO ALPHA TEKNOVA INC -- $8,027.67 2,107 BP7L561
0.01% HUMA HUMACYTE INC -- $7,601.00 7,601 BMYTJP4
0.01% CRBU CARIBOU BIOSCIENCES INC -- $7,468.37 3,679 BNYJR68
0.01% QSI QUANTUM-SI INC -- $7,095.41 7,694 BNR5QT9
0.01% PYXS PYXIS ONCOLOGY INC -- $6,745.75 2,453 BLBR8D5
0.01% LFCR LIFECORE BIOMEDICAL INC -- $6,628.50 1,473 2517058
0.01% BDTX BLACK DIAMOND THERAPEUTICS I -- $6,591.48 2,242 BKTV702
0.01% MENS JYONG BIOTECH LTD -- $6,048.54 2,922 BPTK6Z2
0.01% AARD AARDVARK THERAPEUTICS INC -- $4,907.76 858 BTXQTX3
0.01% PEPG PEPGEN INC -- $4,603.60 2,708 BMTX3D7
0.01% RANI RANI THERAPEUTICS HOLDINGS-A -- $4,109.87 3,841 BNNXX18
-- GOSS GOSSAMER BIO INC -- $3,085.90 9,111 BJ0CK86
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
37.71% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 28,586,456 -- 4,820 --
27.57% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 20,900,139 -- 3,524 --
26.40% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 20,010,519 -- 3,374 --
20.65% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 15,651,381 -- 2,639 --
17.22% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 13,053,691 -- 2,201 --
4.95% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 3,754,196 -- 633 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $26,638,562.04 26,638,562 --

Index

as of 3/31/2026

  • Total Number of Companies256
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.50 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.